Contact | Sitemap | About Medicines Research Responsibility News Investors Careers About Home / About Senior Management Worldwide Operations Ethics Business Conduct Business Partnerships Corporate History Timeline Share Advancing Therapeutics, Improving Lives Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults. Strength Through Partnership Collaborations of all kinds – with partners in science, academia, business and local communities – are central to our work. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible. Growing Worldwide Reach Gilead was founded in 1987 in Foster City, California. Since then, we have grown to become one of the world’s largest biopharmaceutical companies, with 8,000 employees across six continents. At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. 2015 Annual Review About Gilead Senior Management Worldwide Operations Ethics Business Conduct Business Partnerships Corporate History Timeline Research Pipeline Clinical Trials Investigator Sponsored Research Medicines Request Information Consumer Product Safety Authorized Distributors of Record Product Approval Timeline Responsibility U.S. Patient Access Developing World Access Corporate Contributions Policy Perspectives Gilead Foundation News Press Releases Events Media FAQs Fact Sheets Media Inquiries Investors Recent News Corporate Governance Stock Information Financial Information SEC Filings Shareholder Center Annual Reports Email Alerts Investor FAQs Investor Contacts Investor Disclaimer Careers Pipeline Our Values Developing-World-Access Corporate-Contributions U.S. Benefits © 2009-2016 Gilead. All rights reserved. Terms of Use | Privacy Statements Product images shown do not represent actual size.